| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.73 Billion | USD 46.37 Billion | 16.90% | 2024 |
FrequentlyAsked Questions
Synthetic blood substitutes and blood product industry deals with the development, production, and application of artificial blood and essential blood components in case of medical emergency or for research purposes.
The global synthetic blood substitutes and blood products market is expected to be driven by the rising cases of complications associated with traditional blood transfusions.
According to study, the global synthetic blood substitutes and blood product market size was worth around USD 9.73 billion in 2024 and is predicted to grow to around USD 46.37 billion by 2034.
The CAGR value of synthetic blood substitutes and blood product market is expected to be around 16.90% during 2025-2034.
The global synthetic blood substitutes and blood product market is expected to be led by North America during the forecast period.
The global synthetic blood substitutes and blood product market is led by players like HemoBioTech Inc., Aurum Biosciences Ltd, NuvOx Pharma LLC, FluorO2 Therapeutics, Hemoglobin Oxygen Therapeutics LLC, Hemarina SA, Dentritech Inc., Baxter International Inc., Biopure Corporation, KaloCyte Inc., SpheriTech Ltd, Northfield Laboratories Inc., Alpha Therapeutic Corp., Dextro‑Sang Corp. and Sangart Inc.
The report explores crucial aspects of the synthetic blood substitutes and blood product market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients